nach oben

Journal of Nephrology

Erschienen in:

05.08.2023 | original Article

Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy

verfasst von: Limei Xiong, Lili Liu, Yuhong Tao, Hui Guo

Erschienen in: Journal of Nephrology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Mesangial IgM and C3 deposition is commonly observed in patients with primary immunoglobulin A nephropathy (IgAN), but its characteristics and prognosis have rarely been reported. The aim of this study was to investigate the relationship between combined mesangial IgM and C3 deposition and disease progression in children with IgAN.

Methods

One hundred sixteen children diagnosed with IgAN between 2016 and 2020 were selected. Renal biopsies were scored by Oxford classification including the presence of mesangial hypercellularity, endocapillary hypercellularity, segmental glomerulosclerosis, tubular atrophy/interstitial fibrosis and crescents. The primary renal outcome was an event of either ≥ 50% reduction of eGFR from the baseline value or the onset of end-stage renal disease within the follow-up period. Cox regression analysis was performed to examine the effect of the combined mesangial IgM and C3 deposition on renal outcomes.

Results

Forty-seven (40.52%) patients presented combined mesangial IgM and C3 deposition. Compared with children without combined IgM and C3 deposition, children with combined IgM and C3 deposition presented higher mesangial hypercellularity, endocapillary hypercellularity and cresentic lesions in kidney biopsies, and higher prevalence of renal dysfunction (19.15% versus 2.90%; P = 0.007). Renal outcome was also significantly worse as revealed by Kaplan–Meier curves (P = 0.0034). Multivariable Cox analysis identified tubular atrophy/interstitial fibrosis lesions [hazard ratio (HR) 14.843, 95% CI, 3.497–62.997, P < 0.001] and intensity of IgM deposition (HR 2.838, 95% CI, 1.321–6.094, P = 0.007) as independent risk factors for poor renal function.

Conclusions

Combined mesangial IgM and C3 deposition was associated with unfavorable histopathological features. Mesangial IgM deposition was an independent risk factor for poor renal outcomes in children with primary IgAN.

Graphical abstract

Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 66(3):920–923. https://doi.org/10.1111/j.1523-1755.2004.00837.xCrossRefPubMed

Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368(25):2402–2414. https://doi.org/10.1056/NEJMra1206793CrossRefPubMed

Cho BS, Hahn WH, Cheong HI et al (2013) A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management. Clin Exp Nephrol 17(2):205–210. https://doi.org/10.1007/s10157-012-0672-9CrossRefPubMed

Shibano T, Takagi N, Maekawa K et al (2016) Epidemiological survey and clinical investigation of pediatric IgA nephropathy. Clin Exp Nephrol 20(1):111–117. https://doi.org/10.1007/s10157-015-1129-8CrossRefPubMed

Moresco RN, Speeckaert MM, Delanghe JR (2015) Diagnosis and monitoring of IgA nephropathy: the role of biomarkers as an alternative to renal biopsy. Autoimmun Rev 14(10):847–853. https://doi.org/10.1016/j.autrev.2015.05.009CrossRefPubMed

D’Amico G (2000) Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36(2):227–237. https://doi.org/10.1053/ajkd.2000.8966CrossRefPubMed

Rizk DV, Maillard N, Julian BA et al (2019) The emerging role of complement proteins as a target for therapy of IgA nephropathy. Front Immunol 10:504. https://doi.org/10.3389/fimmu.2019.00504CrossRefPubMedPubMedCentral

Katafuchi R, Nagae H, Masutani K et al (2019) Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Clin Exp Nephrol 23(2):169–181. https://doi.org/10.1007/s10157-018-1619-6CrossRefPubMed

Mizerska-Wasiak M, Such-Gruchot A, Cichoń-Kawa K et al (2021) The role of complement component C3 activation in the clinical presentation and prognosis of IgA Nephropathy-A National Study in Children. J Clin Med 10(19):4405. https://doi.org/10.3390/jcm10194405CrossRefPubMedPubMedCentral

10.

Nam KH, Joo YS, Lee C et al (2020) Predictive value of mesangial C3 and C4d deposition in IgA nephropathy. Clin Immunol (Orlando, Fla) 211:108331. https://doi.org/10.1016/j.clim.2019.108331CrossRef

11.

Heybeli C, Oktan MA, Yıldız S et al (2019) Clinical significance of mesangial IgM deposition in patients with IgA nephropathy. Clin Exp Nephrol 23(3):371–379. https://doi.org/10.1007/s10157-018-1651-6CrossRefPubMed

12.

Tan L, Tang Y, Pei GQ et al (2021) Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study. Clin Exp Med 21(4):599–610. https://doi.org/10.1007/s10238-021-00703-1CrossRefPubMed

13.

Strassheim D, Renner B, Panzer S et al (2013) IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol 24(3):393–406. https://doi.org/10.1681/asn.2012020187CrossRefPubMedPubMedCentral

14.

Zhang YM, Gu QH, Huang J et al (2016) Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol CJASN 11(9):1582–1589. https://doi.org/10.2215/cjn.01190216CrossRefPubMed

15.

Berger SP, Roos A, Daha MR (2005) Complement and the kidney: what the nephrologist needs to know in 2006? Nephrol Dial Transpl 20(12):2613–2619. https://doi.org/10.1093/ndt/gfi166CrossRef

16.

Trimarchi H, Barratt J, Cattran DC et al (2017) Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91(5):1014–1021. https://doi.org/10.1016/j.kint.2017.02.003CrossRefPubMed

17.

Li LT, Shi MY, Wei SY et al (2013) Huai Qi Huang ameliorates proteinuria and hematuria in mild IgA nephropathy patients: a prospective randomized controlled study. J Form Med Assoc Taiwan Yi Zhi 112(12):766–772. https://doi.org/10.1016/j.jfma.2013.10.019CrossRef

18.

Tortajada A, Gutierrez E, Pickering MC et al (2019) The role of complement in IgA nephropathy. Mol Immunol 114:123–132. https://doi.org/10.1016/j.molimm.2019.07.017CrossRefPubMed

19.

Al Hussain T, Hussein MH, Al Mana H et al (2017) Pathophysiology of IgA nephropathy. Adv Anat Pathol 24(1):56–62. https://doi.org/10.1097/pap.0000000000000134CrossRefPubMed

20.

Roos A, Bouwman LH, van Gijlswijk-Janssen DJ et al (2001) Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167(5):2861–2868. https://doi.org/10.4049/jimmunol.167.5.2861CrossRefPubMed

21.

Wu J, Hu Z, Wang Y et al (2021) Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy. Histopathology 78(6):882–895. https://doi.org/10.1111/his.14318CrossRefPubMed

22.

Xie M, Zhu Y, Wang X et al (2022) Predictive prognostic value of glomerular C3 deposition in IgA nephropathy. J Nephrol. https://doi.org/10.1007/s40620-022-01363-4CrossRefPubMed

23.

Moriyama T, Shimizu A, Takei T et al (2010) Characteristics of immunoglobulin A nephropathy with mesangial immunoglobulin G and immunoglobulin M deposition. Nephrology (Carlton) 15(8):747–754. https://doi.org/10.1111/j.1440-1797.2010.01296.xCrossRefPubMed

24.

Coppo R (2019) Pediatric IgA nephropathy in Europe. Kidney Dis (Basel, Switzerland) 5(3):182–188. https://doi.org/10.1159/000495751CrossRefPubMedCentral

25.

Coppo R, Lofaro D, Camilla RR et al (2017) Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Pediatr Nephrol (Berlin, Germany) 32(1):139–150. https://doi.org/10.1007/s00467-016-3469-3CrossRef

Titel: Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy
verfasst von: Limei Xiong
Lili Liu
Yuhong Tao
Hui Guo
Publikationsdatum: 05.08.2023
Verlag: Springer International Publishing
Erschienen in: Journal of Nephrology / Ausgabe 8/2023
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-023-01724-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy

Abstract

Background

Methods

Results

Conclusions

Graphical abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2023

Clinicopathological characteristics and outcomes of lupus nephritis patients with scanty immune depositions in kidney biopsies

Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage

Atypical HUS with multiple complement system mutations triggered by synthetic psychoactive drug abuse: a case report

Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis

General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis

Lipoprotein glomerulopathy with membranoproliferative pattern in a patient with cholestatic liver disease—lesson for the clinical nephrologist

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin